New Study Reveals Colorectal Cancer Rates Are Rising Across Older Age Groups Beyond Younger Demographics

While much of the public health conversation in recent years has focused heavily on the alarming rise of colorectal cancer among younger adults, a new study reveals that older age groups are experiencing increases as well, pointing to broader underlying trends that extend across generations.

Published on October 27 in NEJM Evidence, the study examined long-term trends and found that colorectal cancer rates are rising across all age groups up to adults aged 65 to 69. According to the research, overall incidence rates for the studied demographics fell from 55.2 per 100,000 in the year 2000 down to 36.7 per 100,000 in 2022, before experiencing a notable rebound to 38.3 per 100,000 in 2023.

The findings complicate the prevailing narrative that the growing burden of colorectal cancer is strictly confined to younger populations. For years, medical professionals and researchers have sounded the alarm over increasing diagnoses in patients under the age of 50, a trend that has puzzled the oncology community. However, this new research suggests that whatever systemic factors are driving the disease among younger individuals may also be influencing older demographics.

"There are many unique challenges when you’re diagnosed with cancer at a young age, so it’s important that we shine a spotlight on that problem," said Caitlin Murphy, a study author and professor of pediatrics and public health sciences at the University of Chicago, in a news release discussing the findings. "But in terms of understanding the root cause, I think our study shows that we can consider that whatever might be causing colorectal cancer in younger people is now also causing it to increase in older people as well."

To uncover these patterns, the researchers utilized comprehensive data provided by the National Cancer Institute spanning a 20-year period, allowing them to track incidence shifts with a high degree of precision across multiple generations. Among their key findings was the identification of which specific demographic experienced the sharpest surge in diagnoses. According to the study, the most dramatic increase in incidence rates occurred among the 45 to 49 age group, which saw a staggering increase of 12.76% annually from 2019 to 2023.

The study authors attribute this particularly sharp spike in the 45-to-49-year-old cohort largely to increased screening efforts. In recent years, major health organizations and national advisory bodies lowered the recommended age to begin routine colorectal cancer screenings from 50 down to 45 in response to the growing burden of the disease in younger adults.

This policy change successfully mobilized healthcare providers and patients alike, leading to a surge in preventative colonoscopies and other screening modalities within that specific age bracket. Consequently, health systems began detecting precancerous polyps and early-stage malignancies that previously might have gone unnoticed until symptoms developed later in life.

"That means that screening is doing as we intend it to do — it’s catching cancer earlier," Murphy added, emphasizing the public health success of the expanded screening guidelines.

However, researchers caution that while increased screening successfully explains the sudden spike observed in adults aged 45 to 49, it does not fully account for the broader rise in incidence overall or across other age-specific groups captured in the study. The fact that rates are ticking upward in older populations not directly impacted by the shifting of the initial screening age suggests that unknown risk factors may be at play. Researchers note these unidentified environmental, dietary, or lifestyle factors could be actively offsetting the undeniable gains achieved through early detection and preventative screenings.

These findings arrive amid a shifting landscape regarding the lethality and prevalence of the disease in the United States. According to evidence from the American Cancer Society published on January 22 in the Journal of the American Medical Association, colorectal cancer has become the leading cause of cancer-related death among people under 50 in the United States. The data highlighted a dramatic epidemiological shift, showing that colorectal cancer jumped from being the fifth-leading cause of cancer death in that younger age group in the early 1990s to the absolute leading cause by 2023.

As researchers continue to analyze data from the National Cancer Institute and other public health registries, the intersection of rising baseline incidence and the impact of expanded screening guidelines remains a critical focus for oncologists, epidemiologists, and public health officials alike. With rates climbing not just among the younger cohorts that have dominated recent headlines, but also stretching upward into older populations up to age 69, the medical community faces an urgent imperative to identify the root causes driving this multi-generational increase in colorectal cancer.